DANIEL BRADBURY - 02 Jun 2023 Form 4 Insider Report for CASTLE BIOSCIENCES INC (CSTL)

Role
Director
Signature
/s/ Greg Acosta, Attorney-in-fact
Issuer symbol
CSTL
Transactions as of
02 Jun 2023
Net transactions value
$0
Form type
4
Filing time
06 Jun 2023, 16:44:36 UTC
Previous filing
30 May 2023
Next filing
11 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CSTL Common Stock Options Exercise +3,825 +461% 4,655 02 Jun 2023 Direct F1
holding CSTL Common Stock 139,539 02 Jun 2023 By LLC F2
holding CSTL Common Stock 77,780 02 Jun 2023 By Daniel Bradbury Irrecovable Descendant's Trust F3
holding CSTL Common Stock 77,805 02 Jun 2023 By Annette Bradbury Irrecovable Descendant's Trust F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CSTL Restricted Stock Units Options Exercise $0 -3,825 -100% $0.000000* 0 02 Jun 2023 Common Stock 3,825 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
F2 Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares.
F3 Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.
F4 Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.
F5 The RSUs vested in full on the one-year anniversary of the date of grant on June 2, 2023.